Breaking News Instant updates and real-time market news.

NTRA

Natera

$11.09

0.19 (1.74%)

06:07
04/19/18
04/19
06:07
04/19/18
06:07

Natera comfortable with current business trends, says Piper Jaffray

After meeting with management, Piper Jaffray analyst William Quirk says Natera continues to press ahead with near and longer-term catalysts and appeared comfortable with current business trends. Noninvasive prenatal testing reimbursement for fee for service Medicaid, which represents 15% of the company's revenue, is trending positively and management is optimistic about an American College of Obstetricians and Gynecologists endorsement, Quirk tells investors in a research note. He believes Natera is confident of its march towards cash-flow break even and reiterates an Overweight rating on the shares with a $17 price target.

NTRA Natera
$11.09

0.19 (1.74%)

11/14/17
ADAM
11/14/17
NO CHANGE
Target $15
ADAM
Buy
Natera Q3 results strong, oncology update bullish, says Canaccord
Canaccord analyst Mark Massaro noted Natera reported strong Q3 results and showed signs of price stabilization and progress in cancer liquid biopsies. The analyst noted shares have been weak recently, which he believes is partially due to profit-taking following its gains over the past eight weeks. He lowered his estimates near-term due to uncertainty surrounding the timing of ACOG but said its progress on cancer liquid biopsies has led to eight contracts with pharma companies since launch in Q2. Massaro reiterated his Buy rating but lowered his price target to $15 from $16 on Natera shares.
01/02/18
PIPR
01/02/18
NO CHANGE
PIPR
Overweight
UnitedHealth update removes upside source for Natera, says Piper Jaffray
UnitedHealth (UNH) updated its non-invasive prenatal testing medical policy, continuing to only cover the test in high risk women, Piper Jaffray analyst William Quirk tells investors in a research note. The analyst says that while his estimates for Natera are unchanged, UnitedHealth's decision does remove one of the potential sources of 2018 upside for the shares. Aetna (AET) is the other large payer not covering average risk non-invasive prenatal testing, and an update from the insurer is likely in Mayor June, Quirk writes. He keeps an Overweight rating on Natera shares.
01/17/18
EAMC
01/17/18
INITIATION
Target $5
EAMC
Sell
Natera initiated with a Sell at Empire
Empire initiated Natera with a Sell and $5 price target.
04/09/18
CHLM
04/09/18
INITIATION
Target $16
CHLM
Buy
Natera initiated with a Buy at Craig-Hallum
Craig-Hallum analyst Alexander Nowak started Natera with a Buy rating and $16 price target as he believes the headwinds of the last three years are now behind the company.

TODAY'S FREE FLY STORIES

BABA

Alibaba

$162.44

5.8 (3.70%)

14:18
09/19/18
09/19
14:18
09/19/18
14:18
Recommendations
Alibaba analyst commentary  »

Stifel still confident in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

14:17
09/19/18
09/19
14:17
09/19/18
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

14:16
09/19/18
09/19
14:16
09/19/18
14:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPOT

Spotify

$169.33

-6.1 (-3.48%)

14:16
09/19/18
09/19
14:16
09/19/18
14:16
Periodicals
Spotify accused of ' fostering a negative work culture for women,' Verge says »

Music streaming company…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BABA

Alibaba

$162.49

5.85 (3.73%)

14:13
09/19/18
09/19
14:13
09/19/18
14:13
Periodicals
Alibaba no longer plans to bring 1M jobs to U.S. in wake of trade war, CNBC says »

Alibaba founder and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

SAFM

Sanderson Farms

$100.90

-2.04 (-1.98%)

14:09
09/19/18
09/19
14:09
09/19/18
14:09
Hot Stocks
Sanderson Farms reports on impact to operations from Hurricane Florence »

Sanderson Farms reported…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Oct

  • 06

    Nov

14:08
09/19/18
09/19
14:08
09/19/18
14:08
Conference/Events
RBC Capital internet analyst to hold a luncheon »

Internet Analyst Mahaney…

14:06
09/19/18
09/19
14:06
09/19/18
14:06
Conference/Events
RBC Capital multi-industry analyst to hold group luncheon »

Multi-Industry Analyst…

14:04
09/19/18
09/19
14:04
09/19/18
14:04
Conference/Events
RBC Capital biotech analysts to hold a group breakfast »

Biotech Gene Therapy…

CZR

Caesars

$10.90

0.1 (0.93%)

14:00
09/19/18
09/19
14:00
09/19/18
14:00
Options
Caesars option volume is 2X daily average and calls lead puts 10:1 »

Caesars option volume is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ELAN

Elanco

$0.00

(0.00%)

, LLY

Eli Lilly

$105.83

-1.06 (-0.99%)

13:51
09/19/18
09/19
13:51
09/19/18
13:51
Initiation
Elanco, Eli Lilly initiated  »

Elanco initiated with a…

ELAN

Elanco

$0.00

(0.00%)

LLY

Eli Lilly

$105.83

-1.06 (-0.99%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

  • 01

    Oct

  • 04

    Oct

  • 20

    Sep

LFUS

Littelfuse

$204.06

-9.68 (-4.53%)

13:41
09/19/18
09/19
13:41
09/19/18
13:41
Recommendations
Littelfuse analyst commentary  »

Use weakness to buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Sep

MRK

Merck

$70.16

-0.26 (-0.37%)

, BMY

Bristol-Myers

$60.93

-0.55 (-0.89%)

13:36
09/19/18
09/19
13:36
09/19/18
13:36
Periodicals
Merck cuts key cancer drug price for China launch, Caixin reports »

Merck (MRK) will cut the…

MRK

Merck

$70.16

-0.26 (-0.37%)

BMY

Bristol-Myers

$60.93

-0.55 (-0.89%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

  • 22

    Oct

  • 23

    Oct

  • 25

    Oct

  • 29

    Oct

  • 11

    Jan

  • 16

    Feb

GLUU

Glu Mobile

$7.30

-0.285 (-3.76%)

13:35
09/19/18
09/19
13:35
09/19/18
13:35
Options
Glu Mobile put volume heavy and directionally bearish »

Bearish flow noted in Glu…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

REV

Revlon

$23.75

0.5 (2.15%)

, TLRY

Tilray

$227.50

72.51 (46.78%)

13:34
09/19/18
09/19
13:34
09/19/18
13:34
Periodicals
Revlon could be set for short squeeze similar to Tilray's, Mox Reports says »

Mox Reports, which has…

REV

Revlon

$23.75

0.5 (2.15%)

TLRY

Tilray

$227.50

72.51 (46.78%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TTWO

Take-Two

$129.93

-2.76 (-2.08%)

, SNE

Sony

$59.02

-0.8 (-1.34%)

13:32
09/19/18
09/19
13:32
09/19/18
13:32
Hot Stocks
Take-Two's Rockstar announces 'Red Dead Online' »

Take-Two's (TTWO)…

TTWO

Take-Two

$129.93

-2.76 (-2.08%)

SNE

Sony

$59.02

-0.8 (-1.34%)

MSFT

Microsoft

$111.22

-2.02 (-1.78%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

  • 21

    Oct

  • 28

    Oct

  • 28

    Nov

  • 03

    Mar

13:30
09/19/18
09/19
13:30
09/19/18
13:30
General news
Hurricane Florence »

Hurricane Florence has…

13:30
09/19/18
09/19
13:30
09/19/18
13:30
General news
U.S. equities remain mixed with the Dow up »

U.S. equities remain…

AMZN

Amazon.com

$1,913.86

-27.34 (-1.41%)

13:29
09/19/18
09/19
13:29
09/19/18
13:29
Technical Analysis
Technical Take: Amazon.com attempting to bounce off third support test »

The shares are down over…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HEAR

Turtle Beach

$19.61

1.86 (10.48%)

13:25
09/19/18
09/19
13:25
09/19/18
13:25
Options
Turtle Beach call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WCN

Waste Connections

$79.49

-0.695 (-0.87%)

13:25
09/19/18
09/19
13:25
09/19/18
13:25
Conference/Events
Waste Connections participates in a conference call with UBS »

Analyst Windham holds a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

13:17
09/19/18
09/19
13:17
09/19/18
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

13:16
09/19/18
09/19
13:16
09/19/18
13:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DRI

Darden

$117.54

-1.39 (-1.17%)

13:10
09/19/18
09/19
13:10
09/19/18
13:10
Options
Darden Restaurants with a bullish option play ahead of earnings »

Darden Restaurants with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 20

    Sep

  • 11

    Oct

SSNLF

Samsung

$0.00

(0.00%)

13:09
09/19/18
09/19
13:09
09/19/18
13:09
Periodicals
Samsung may be working on 5G variant of Galaxy 10, XDA-Developers says »

Samsung may be planning…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.